BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13) (Middle Region) Peptide
BCL2L13
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BCL2L13 products
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
- Protein Region
- Middle Region
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCL2L13 antibody (Catalog #: AVARP02032_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
- Synonyms
- si:ch211-238n5.7 Peptide, Mil1 Peptide, BCL-RAMBO Peptide, Bcl2-L-13 Peptide, MIL1 Peptide, E430016C20Rik Peptide, Mil-1 Peptide, BCL2 like 13 Peptide, BCL2-like 13 (apoptosis facilitator) Peptide, BCL2L13 Peptide, bcl2l13 Peptide, Bcl2l13 Peptide
- Background
-
BCL2L13 May promote the activation of caspase-3 and apoptosis.
Alias Symbols: BCL-RAMBO, MIL1, Bcl2-L-13
Protein Interaction Partner: GABARAPL2,GABARAPL2
Protein Size: 485 - Molecular Weight
- 53 kDa
- Gene ID
- 23786
- NCBI Accession
- NM_015367, NP_056182
- UniProt
- Q9BXK5
-
You are here:
